Aims: Marijuana is a widely used illicit drug and its consumption during pregnancy has been associated with adverse reproductive outcomes. The purpose of this study was to determine the effects of chronic intake of Δ⁹-tetrahydrocannabinol (THC), the major component of marijuana, on trophoblast function, placental development, and birth outcomes. Methods: The pathological characteristics and distribution of cannabinoid receptors in placenta were observed by immunohistochemical (IHC) staining. Cell migration in response to THC was measured by transwell assays. The levels of cannabinoid receptors and Signal Transducer and Activator of Transcription 3 (STAT3) were detected by western blot. Results: We found the placenta expressed two main cannabinoid receptors, suggesting that THC induced biological responses in placental cells. Supporting this hypothesis, we observed dramatic alterations of placental morphology in marijuana users. Using THC and inhibitors of cannabinoid receptors, we demonstrated that THC impaired trophoblast cell migration and invasion partly via cannabinoid receptors. Additionally, pregnant mice injected with THC showed adverse reproductive events including reduced number of fetuses, lower maternal and placental weights. Mechanistically, STAT3 signaling pathway was involved in the THC-induced suppression of trophoblast cell motility and pregnancy outcomes. Conclusion: Our study indicates that the STAT3 signaling pathway plays a critical role in THC-induced trophoblast dysfunction.
Suppression of STAT3 Signaling by Δ⁹-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction

Introduction
Marijuana, one of the most frequently used illicit drugs around the word, is made from the whole plant (dried leaves, flowers, stems and seeds) of the hemp plant (Cannabis sativa) [1] . In 2013, 7.5% of the US population reported using marijuana within the last month of survey [2] . Currently, more than 60 types of Cannabinoids, the terpenophenolic constituents Drugs Δ⁹-tetrahydrocannabinol (THC, 10mg/mL in ethanol solution) was purchased from Cerilliant (SigmaAldrich, St. Louis, MO, USA) and stored at -20 0 C. SR141716 (Rimanonbant) was from Selleckchem (Houston, TX, USA). SR144528 was purchased from SANOFI Research (Montpellier, France). Cryptotanshinone (CTP) was purchased from Selleckchem (Houston, TX, USA). They were initially dissolved in DMSO to a concentration of 10mM and stored at -80℃.
H&E and IHC
Placental tissues were immersion-fixed in 4% buffered formalin and then transferred to paraffin. Tissue sections of 3-5μM in thickness were cut from the paraffin-embedded tissues, and mounted on poly-L-lysine-coated slides and then deparaffinized in xylene, dehydrated in alcohol then stained with the H&E. Some sections were stained for CB1R (1:100; Abcam, Cambridge, MA), CB2R (1:100; Abcam) and pSTAT3 (1:100; Cell Signaling Technology (CST) Danvers, MA), respectively using the streptavidin-biotinhorseradish peroxidase complex formation method.
RNA extraction and cDNA synthesis
Total tissue RNA was extracted by using the TRIzol reagent (Invitrogen™, Carlsbad, CA, USA) and the RNA simple Total RNA Kit (Tiangen, Beijing, China) according to the manufacturer's instructions. The concentration of RNA was quantified using the NanoDrop 2000c Spectrophotometer (Nano-Drop Technologies, Wilmington, DE, USA). The purity of the RNA extracts was high as indicated by the A260/280 nm ratios that ranged from 1.9-2.1. The RNA was treated with RNase-free DNase (Tiangen) before reverse transcription to eliminate amplification of residual amounts of genomic DNA in the RNA extracts. The RNA was converted to cDNA using the PrimeScript RT reagent kit (TaKaRa, Dalian, China). The reaction conditions were performed at 37 °C for 20 minutes followed by 85 °C for 5 seconds on an Eppendorf thermocycler.
Quantitative RT-PCR analysis
Real-time quantitative reverse transcription-polymerase chain reaction (qPCR) was carried out to evaluate the levels of CB1, CB2 receptor mRNA expression using the SYBR Green Premix Ex Taq (Tiangen) on an ABI Prism 7000 Sequence Detection System (Life Technology). The primer sequences for real-time PCR analysis are as follows: human CB1 receptor -forward primer 5'-TTACAACAAGTCTCTCTCGTCCT-3', and reverse primer 5'-GGCTGCCGATGAAGTGGTA-3'; human CB2 receptor -forward primer 5'-GGGTGACAGAGATAGCCAATGG-3', and reverse primer 5'-TGAACAGGTATGAGGGCTTCC-3'; The relative levels were normalized to the control human GAPDH mRNA, the primer sequence was forward 5'-AGGGCTGCTTTTAACTCTGGT-3' and reverse 5'-CCCCACTTGATTTTGGAGGGA-3'. Mouse CB1 receptorforward primer 5'-CTTAGACGGCCTTGCAGATAC -3', and reverse primer 5'-GGATGCCATGTCTCCTTTGATA -3'; Mouse CB2 receptor -forward primer 5'-GGGTCCTCTCAGCATTGATTT-3', and reverse primer 5'-AGCCCAGTAGGTAGTCGTTAG-3'; The relative levels were normalized to control mouse GAPDH mRNA, the primer sequences were forward 5'-CAGTATGACTCCACTCACGGCAA-3' and reverse 5'-CTCGCTCCTGGAAGATGGTGAT-3'. The real-time PCR reactions were carried out for 30s at 95°C and then 40 cycles of 15s at 95°C and 20s at 56°C. To confirm the amplification specificity, the PCR products were subjected to melting curve analyses. Relative mRNA levels were calculated using the 2 -△△CT method.
Western Blot analysis
For analysis of cannabinoid CB1R, CB2R, STAT3 and pSTAT3 Y705 expression, placental tissues and HTR-8/SVneo and BeWo cells were lysed in RIPA Lysis buffer, then homogenized by vigorous mixing for 30 min on ice, and centrifuged at 13000 x g for 20min. Total protein concentration was measured using Table. 1 Characteristics of pregnant women and patients exposed to marijuana. All the data are expressed as mean ± S.E.M. *p<0.05 the bicinchoninic acid assay (Pierce®, Thermo Fisher Scientific, Bonn, Germany). Proteins were separated on 10% sodium dodecyl sulfate polyacrylamide gels. Following transfer to PVDF membranes and blocking with 5% non-fat milk powder, blots were probed with the following antibodies, CB1R (1:1000, Abcam), CB2 R (1:1000, Abcam), STAT3 (1:2000, CST), p-STAT3 Y705 (1:1000, CST), β-actin (1:5000, Abmart, Shanghai, China) and GAPDH (1:10000, Abmart) at 4℃ overnight. Subsequently, membranes were washed and incubated with horseradish peroxidase-conjugated Fab-specific anti-mouse IgG (1:5000, CST) or anti-rabbit IgG (1:3000, CST). Ultimately, proteins were visualized using the enhanced chemiluminescence reagents (Thermo Scientific), and the relative expression of CB1R, CB2R, STAT3 and pSTAT3 Y705 protein levels were analyzed by densitometry using the Image-J imaging analysis software (NIH, Bethesda, MD).
Cell culture HTR-8/SVneo and BeWo human trophoblast cell lines obtained from ATCC (Rockville, MD, USA) were maintained (passages [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] at 37℃ in a humidified atmosphere with 5% CO 2 and 95% air. Cells were cultured in 75-cm 2 flasks in DMEM/F-12(1:1) medium (Gibco, Grand Island, NY, USA) with 10% fetal bovine serum (Gibco) and 1% P/S.
Cell proliferation assay
To test the effect of THC on HTR-8/SVneo and BeWo cell proliferation, 3 x 10 3 cells per well were plated in 96-well culture plates in 100 μL of DMEM/F12 medium. The medium was changed to one that contained different doses of THC (0-30μM) for 48 and 96h with fresh medium replaced at 48h. After 48 and 96h, relative cell numbers were determined using the MTS (Promega) reagent in a 96-well plate reader at 490nm. Cell numbers were obtained by calibration against a standard curve of untreated HTR-8/SVneo and BeWo cell numbers grown in parallel. To make direct comparisons between cultures, we then converted the cell numbers to a percentage of the 1% methanol control cells.
Cell migration and invasion assay
Migration of HTR-8/SVneo and BeWo cells was determined using a modified system according to the manufacturer's instructions (BD Bioscience, Heidelberg, Germany). In this assay, cell migration towards a chemoattractant was monitored using a 24-well transwell plate with insert of 8μm in pore size. In brief, 5 x 10 4 cells were seeded on the upper side of the transwell inserts in serum free medium. DMEM/F12 containing 10% FBS supplemented with test substances or vehicle alone were used as chemoattractant in the companion plate. Following incubation at 37℃ with 5% CO 2 and 95% air for 16 hours, the fluorescent stain (calcein-AM) was added to each chamber and incubated for 30 minutes. The numbers of migrated cells was determined by fluorescence image analysis (Nikon, Japan).
The capacity of HTR-8/SVneo cells to invade Matrigel was determined using 24-well transwell plates (BD Bioscience, Becton Dickinson GmbH, Heidelberg, Germany). In this assay, the upper chamber of the insert was pre-coated with 60μL of a 1: 10 dilution of Matrigel (BD Biosciences) in standard medium for 60 min at 37°C. After hydration by PBS for 60 min, 1.5 x 10 5 cells were seeded into the upper side of the transwell inserts in serum free medium. DMEM/F12 containing 10% FBS was used as chemoattractant in the companion plate. Following incubation at 37℃ with 5% CO 2 and 95% air for 24 hours, fluorescent stain was added to each chamber and incubated for 30 minutes. The numbers of invading cells were counted by fluorescence analysis (Nikon, Japan).
Animal studies
For a consistent and accurate assessment of the gestational age of mouse embryos, C57BL/6 males (n=20, 18-22g) and females (n=40, 18-22g) mice were pair housed (two females: one male) for one night and the next morning females were examined for the presence of a vaginal plug. The day when a vaginal plug was first noted was designated day 0.5 (GD0.5). Pregnant mice (n=14) were equally divided into two groups randomly and injected intraperitoneally with THC (5 mg/kg) or vehicle from GD5.5 to GD18.5 daily. Embryos were harvested on GD19.5, and placental tissues were processed as described previously. This project was approved by the Animal Investigation Ethics Committee of the East China Normal University, and mouse studies were performed in accordance with animal protocol procedures approved by the Department of Laboratory Animal Science, East China Normal University.
Results
Histopathological changes and cannabinoid receptors expression in placental tissues of marijuana users
Few studies have examined the morphologic changes induced in the placenta by marijuana at the microscopic level. Therefore, we screened placental tissues for histopathologic changes in three marijuana users by H&E staining. Compared with normal controls (non-users) (Fig.  1a) , marijuana user placentas showed increased syncytiotrophoblastic knots and fibrin exudation in the villous stroma. In addition, women who consumed marijuana had babies that weight less than non-users (Table. 1 ). The results illustrate that pregnant women who smoked marijuana at least once a month without reporting alcohol or tobacco use during pregnancy had an impaired placental development, which may lead to adverse pregnancy outcomes.
IHC analysis of human placental villous tissue obtained at about 7-week of gestation revealed that cannabinoid receptors are abundant in both syncytiotrophoblasts and (Fig. 1b) . The positive brown staining of cannabinoid receptors in the placental tissues show that both CB1R and CB2R are expressed in the placenta tissues. IHC showed that CB1R and CB2R levels were decreased in the placenta of marijuana users compared with normal pregnant women. Next, qPCR and western blotting were used to determine the relative expression of CB1R and CB2R mRNA and protein levels in the placenta. No significant differences of CB1R were found between the first and third trimester placental tissues of non-users, but CB2R mRNA (Fig. 1c ) and protein were (Fig. 1d ) increased in the third trimester tissues, suggesting that CB2R expression is positively correlated with pregnancy progression.
Effect of THC on HTR-8/SVneo and BeWo cell proliferation, migration and invasion
Since appropriate trophoblast function is critical for normal placental development and pregnancy maintenance, we selected the most widely used trophoblast cell lines, HTR-8/ SVneo and BeWo, to determine the effect of THC on cell proliferation, migration and invasion. The THC concentrations used in our studies ranged from 0.3 to 30μM, which was similar with previously study used in vitro [20] . Our data indicated that THC at low doses (0-15μM) did not affect cell proliferation whereas 30μM significantly induced cell death (Fig. 2a) .
Furthermore, we performed trans-well assays to study the impaction of THC on trophoblast cell migration and invasion. THC at a concentration of 3μM had no effects on either cell migration or invasion. However, 15μM of THC significantly impaired HTR-8/ SVneo and BeWo cell migration (Fig. 2b-c) , as well as HTR-8/SVneo cell invasion (Fig. 2d) compared to vehicle treated cells. In this assay, BeWo cells showed week invasive potential on Matrigel, therefore the effects of THC on BeWo invasion was not tested. Taken together, these data suggest that THC disrupts placental development by impairing the migration and invasion capacity of trophoblasts. 
Involvement of cannabinoid receptors in THC-induced changes in placental trophoblast cells
Although THC serves as an agonist of CB1 and CB2 receptors, the mechanism by which trophoblasts respond to THC upon receptor binding is not clear. To begin to answer this question, we first examined the protein levels of CB1R and CB2R before and after treatment of THC. We did not observe significant differences between HTR-8/SVneo and BeWo cells after the treating with THC (Fig. 3a) , suggesting that changes in cannabinoid receptor expression are not required for trophoblasts to respond to THC. Next, we analyzed the effect of SR141716 (CB1 receptor antagonist) [21] , and SR144528 (CB2 receptor antagonist) [22] on cell motility and invasion. Both of them had no obvious effect on trophoblast cell survival. In addition, migration and invasion responses to SR141716 or SR144528 alone or both were not different from that of vehicle treated cells. Although THC reduced the number of migrated cell number compared with the vehicle control, the effect of THC was reversed by pre-treating with the receptor antagonists ( Fig. 3b-d) . Hence, pre-treatment with cannabinoid receptor inhibitors can slightly attenuate the response to THC, which means that the effect of THC on cell migration and invasion is partly dependent on CB1R and CB2R.
The STAT3 signaling pathway is involved in THC-induced trophoblasts dysfunction
Due to dynamic changes in the phosphorylation status of proteins, we examined STAT3 phosphorylation at early time points (1, 2 and 4h) after THC stimulation of trophoblast cells. As shown in Fig. 4a-b (Fig. 4c-d) . Additionally, we observed a significant reduction in the migration potential of HTR-8/SVneo and BeWo cells treated with cryptotanshinone (Fig.  4e) . Moreover, our previous researches have demonstrated that overexpression of STAT3 obviously improved the migration of HTR-8/SVneo trophoblast cells [24] . These results above suggest that STAT3, or signaling events upstream of STAT3, might be targeted by THC in vitro.
Effect of THC exposure on pregnancy outcomes in mice
Pregnant mice were randomly injected with a THC dose of 5mg/kg or diluent from GD 5.5 to 19.5. The training dose of 5mg/kg was chosen because the plasma THC concentration Table. 2 Perinatal outcomes of mice exposure to THC. All the data are expressed as mean ± S.E.M. *p<0.05, **p<0.01 produced by this dose is similar to that described for human marijuana smokers [25] . The characteristics of mice pregnancy outcomes are shown in Table. 2. The body weight of pregnant mice on GD 19.5 ( Fig. 5a ) was significantly decreased in the THC treated group. This decrease in weight was most likely caused by the decreased numbers of fetuses per litter (Fig. 5b) . In addition, the total weights of both the fetuses and placentas and the average weights were clearly reduced (Fig. 5c-d) . The results are in agreement with previous epidemiological surveys and animal studies [2] , indicating that exposure to marijuana during pregnancy may result in adverse reproductive outcomes including fetal loss and intrauterine growth restriction.
Effect of THC on placental histopathology and expression of cannabinoid receptors and phosphorylation of STAT3 in vivo
To explore the potential mechanism of adverse pregnancy events in marijuana users, H&E stained placental tissues obtained from THC treated and vehicle treated mice were histologically examined (Fig. 6a) . Histologic differences in the placenta of THC treated mice were obvious relative to control mice. The placentas of THC treated animals showed clear narrowing of the maternal sinusoids (Fig. 6b, MS) with increased diameters of trophoblastic septa in the labyrinth zone. In addition, the spongiotrophoblasts were disordered in structure and there were significantly fewer glycogen cells in the basal zone (Fig. 6c , Sp, GC). Collectively these histologic changes lead to poor blood and nutrition supply to the developing fetuses in THC exposed animals.
Importantly, we found the activation of STAT3 is inhibited in response to THC in vivo, including the mice exposed to THC (Fig. 6d-e) and in women who used marijuana during pregnancy (Fig. 6g) . Interestingly, we observed that CB1R and CB2R mRNA and protein levels were lower in the THC exposed group (Fig. 6d, f) .
Discussion
Currently, recreational use of marijuana is common among people of reproductive age. However, most studies about chronic substance exposure are related to cigarette smoking [26] , alcohol consumption [27] and cocaine addiction [28] while the hazards of chronic marijuana use especially the effects on trophoblast function and its potential mechanism of influencing pregnancy outcomes is not well researched. THC as one of the major bioactive cannabinoids, has been widely used to study the effects of marijuana on various physiology and pathology processes [29] , thus we provided more insight into the effects of THC on the biological function of human trophoblasts and the potential mechanism underlying the influence of marijuana exposure on placental development during pregnancy.
In this study, we observed increased syncytiotrophoblastic knots and fibrin exudation in the villous stroma of marijuana users by H&E staining, suggesting that marijuana exposure impaired placental development and lead to the changes observed in placenta structure and morphology. These morphologic changes are most probably triggered by an inflammatory response and/or poor supply of nutrients and oxygen when the placental tissue is exposed to THC. In order to eliminate the effects of other potential confounding factors, we selected only three marijuana smokers without tobacco or alcohol addiction. Previously, studies focused on placental pathological characteristics reported that marijuana exposure was associated with larger placenta [30] and no significant differences in the placental villi between controls and marijuana using mothers [31] , while potential effects of marijuana exposure on placental development were still largely unknown. Their findings were not consistent with our present results. Differences in the volume and frequency of marijuana intake and the way study subjects took marijuana in prior studies could explain the lack of agreement between different studies. Costa et al. [32] showed that THC interferes with trophoblast turnover and impaired cytotrophoblasts (CTs) differentiation into syncytiotrophoblasts (STs) in women that consume marijuana during gestation.
In mouse models, we demonstrated that intake of THC during pregnancy resulted in adverse reproductive outcomes. As in human placental specimens from marijuana users, we observed histopathologic changes in the placentas obtained from THC treated mice. We found severe narrowing of the maternal sinusoids and increased diameters of trophoblastic septa in labyrinth zone, which indicated an increased diffusion distance between the fetal and maternal blood supplies that led poor nutrition to the developing fetus [33] . In addition, the disordered structure of spongiotrophoblasts and decreased number of glycogen cells in basal zone were likely responsible for adverse pregnancy outcomes.
It has been reported that cannabinoid receptors are expressed in many organs and tissues including the lung, heart, uterus, embryo and various types of cells particularly in cancer cells. A body of evidence indicates that cannabinoids mediate their biological effects through specific cannabinoid receptors. In this study, we demonstrated that CB1R and CB2R were highly expressed in human placental tissues of both the first and third trimesters. In addition, CB1R and CB2R expression levels appeared to increase at later stages of pregnancy, indicating that endocannabinoid signaling may play an important role in placental development. Indeed endocannabinoid signaling has been widely reported to play a crucial role in reproductive processes including fertilization, implantation, and embryonic growth [34, 35] . Interestingly, we observed that CB1R and CB2R levels in the placenta were significantly decreased in mice injected with THC. Contrary to this, we observed CB1R and CB2R levels were unaffected by THC in cultured trophoblast cells. Both the THC concentration differences and duration of THC exposure to trophoblast cells could explain the discrepancies in CB1R and CB2R expression between in vitro and in vivo experiments upon THC treatment. The lower cannabinoid receptor levels observed were probably related to desensitization of cannabinoid receptors in placentas following the chronic THC treatment. This rationale is consistent with a previous study conducted on the mouse hippocampus [36] .
It was well known that extravillous cytotrophoblast (EVT) invasion is a complex process including attachment to the extracellular matrix (ECM), releasing proteolytic enzymes to break down the ECM then moving through to invade into the decidua. Neither excessive or shallow invasion are implicated in placental dysfunction, which is responsible for pregnancyrelated disorders [37] . Manjiri et al. [20] found that concentrations of Δ9-THC equivalent to those found in the serum of cannabis users (i.e. ∼20 µM) inhibited proliferation of BeWo trophoblast cell line. Our present data indicated that THC (15µM) greatly impaired the biological activity of human trophoblasts, specifically trophoblast migration and invasion. Furtherly, we also confirmed that THC-impaired trophoblast functions were partly mediated by CB1R and CB2R, two main cannabinoid receptors. However, other receptors such as the transient receptor potential cation channel subfamily V member 1 (TRPV1) and the orphan G protein-coupled receptor GPR55 have been proposed to act as endocannabinoid receptors. Current knowledge about GPR55 expression and function in human placenta is very limited, gene expression analysis revealed low GPR55 levels in human placenta, when compared to spleen and lung. Moreover, expression analysis showed increased placental GPR55 expression at term compared to first trimester [38] . Therefore, the effect of THC on trophoblast functions may be mediated by other cannabinoid receptors. This finding was in agreement with previous reports showing that several cannabinoids, including THC and synthetic cannabinoid agonists, were shown to inhibit tumor growth and progression of several types of cancers, such as breast and liver cancers [39] . Studies also showed that CB1R and CB2R were novel targets for inhibition of non-small-cell lung cancer growth and metastasis [40] . The studies of trophoblast function have revealed the striking similarities in molecular circuits between trophoblasts and cancer cells, which may be primarily related to the inherent invasive nature of both cell types.
We shed light on the potential mechanism by which THC modulated human trophoblast biological functions. The STAT3 signaling pathway is involved in the process of cell division, migration and invasion of various cell types. Moreover, STAT3 is detected in primary trophoblast cells isolated from first-trimester placenta and the activity is essential for implantation and pregnancy progression as STAT3 -/ -knockout embryos degenerate and die [41] . Our data showed that STAT3 activation in trophoblasts was remarkably inhibited after exposure to THC. Therefore, we suggested that THC reduced the migration and invasion of human trophoblast cells probably via suppression of STAT3 activation. This was also supported by researches that interleukin-6 (IL-6) greatly increased trophoblast cell migration and invasion via activation of STAT3 signaling pathway [42] . Importantly, we also observed that the STAT3 phosphorylation levels in the placenta were significantly decreased in mice injected with THC and women exposed to marijuana, which was consistent with our in vitro results.
We revealed that THC impaired trophoblast cell migration and invasion through regulating the activation of STAT3 without affecting cell proliferation. Moreover, our study demonstrated that THC caused adverse reproductive events in pregnant mice. In conclusion, marijuana exposure during pregnancy does harm placental and fetal development as THC can impair trophoblast cell migration and invasion through the STAT3 signaling pathway.
The limitations of our study are inherent in research associated with toxicology exposure in pregnancy. First, although most medical histories of marijuana use during pregnancy are collected, but multiple confounding factors (including predominantly lifestyle factors, details of marijuana preparations and the use of marijuana in combination with other drugs) detract from our ability to establish causality. Second, marijuana and other substance use were self-reported and not validated with biological markers. Third, we should collect the information about THC concentration in biological samples (e.g. serum, urine, hair, amniotic fluid, brain fluids) to confirm the exposure amount of marijuana. These above issues probably limited this study to assess the effects of intrauterine exposure to marijuana on placental development.
